References
- Tan G H, Gharib H. Thyroid incidentalomas: management approaches to nonpalpable nodules discovered incidentally on thyroid imaging. Ann Intern Med 1997; 126: 226–231
- Kang K W, Kim S K, Kang H S, Lee E S, Sim J S, Lee I G, et al. Prevalence and risk of cancer of focal thyroid incidentaloma identified by 18F-fluorodeoxyglucose positron emission tomography for metastasis evaluation and cancer screening in healthy subjects. J Clin Endocrinol Metab 2003; 88: 4100–4104
- van den Bruel A, Maes A, De Potter T, Mortelmans L, Drijkoningen M, Van Damme B, et al. Clinical relevance of thyroid fluorodeoxyglucose-whole body positron emission tomography incidentaloma. J Clin Endocrinol Metab 2002; 87: 1517–1520
- Strauss L, Conti P S. The application of PET in clinical oncology. J Nucl Med 1991; 32: 623–648
- Kim T Y, Kim W B, Ryu J S, Gong G, Hong S J, Shong Y K. 18F-fluorodeoxyglucose uptake in thyroid from positron emission tomogram (PET) for evaluation in cancer patients: high prevalence of malignancy in thyroid PET incidentaloma. Laryngoscope 2005; 115: 1074–1078
- Cohen M S, Arslan N, Dehdashti F, Doherty G M, Lairmore T C, Brunt L M, et al. Risk of malignancy in thyroid incidentalomas identified by fluorodeoxyglucose-positron emission tomography. Surgery 2001; 130: 941–946
- Ramos C D, Chisin R, Yeung H W, Larson S M, Macapinlac H A. Incidental focal thyroid uptake on FDG positron emission tomographic scans may represent a second primary tumor. Clin Nucl Med 2001; 26: 193–197
- Schoder H, Noy A, Gonen M, Weng L, Gree D, Erdi Y E, et al. Intensity of 18 fluorodeoxyglucose uptake in positron emission tomography distinguishes between indolent and aggressive non-Hodgkin's lymphoma. J Clin Oncol 2005; 23: 4643–4651
- Sasaki M, Ichiya Y, Kuwabara Y, Akashi Y, Yoshida T, Fukumura T, et al. An evaluation of FDG-PET in the detection and differentiation of thyroid tumours. Nucl Med Commun 1997; 18: 957–963
- Blum R, Prince H M, Hicks R J, Patrikeos A, Seymour J. Discordant response to chemotherapy detected by PET scanning: unveiling of a second primary cancer. Am J Clin Oncol 2002; 25: 368–370
- Beyer T, Townsend D W, Brun T, Kinahan P E, Charron M, Roddy R, et al. A combined PET/CT scanner for clinical oncology. J Nucl Med 2000; 41: 1369–1379